Concord Medical Services Holdings Limited ADS (Each represents three)
| 1.28 | -0.0100 | -0.78% | Vol 301 | 1Y Perf -27.93% |
| Oct 4th, 2023 14:58 DELAYED |
| BID | 1.28 | ASK | 1.35 | ||
| Open | 1.28 | Previous Close | 1.29 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 1.20 | Analyst Rating | — 0.00 | |
| Potential % | -6.25 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ☆ 33.72 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ☆ 23.46 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 26.04 | Earnings Rating | Buy | |
| Market Cap | 55.57M | Earnings Date | 5th May 2023 | |
| Alpha | -0.01 | Standard Deviation | 0.14 | |
| Beta | -0.17 |
Today's Price Range 1.281.28 | 52W Range 1.031.99 | 5 Year PE Ratio Range -3.70-2.00 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -0.78% | ||
| 1 Month | -4.48% | ||
| 3 Months | -6.57% | ||
| 6 Months | -3.40% | ||
| 1 Year | -27.93% | ||
| 3 Years | -37.17% | ||
| 5 Years | -63.74% | ||
| 10 Years | -67.97% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -483.94 | |||
ROE last 12 Months | 70.11 | |||
ROA (5Y Avg) | -6.92 | |||
ROA last 12 Months | -14.26 | |||
ROC (5Y Avg) | -17.59 | |||
ROC last 12 Months | -34.46 | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | -25.53 | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | 0.60 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.80 | ||||
| 3.03 | ||||
| 3.10 | ||||
| 30.60 | ||||
| -0.40 | ||||
| -1.19 | ||||
| -0.18 | ||||
| -5.14 | ||||
| 512.99M | ||||
| Forward PE | -9.14 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.20 | ||||
| 0.70 | ||||
| 0.84 | ||||
| 6.63 | ||||
| -4.40 | ||||
| Leverage Ratio | -4.10 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -33.90 | ||||
| -116.20 | ||||
| -116.20 | ||||
| -150.90 | ||||
| -89.01 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 21.53M | ||||
| 0.50 | ||||
| -19.87 | ||||
| -28.38 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q02 2016 | 0.21 | -0.06 | -128.57 |
| Q01 2016 | 0.12 | -0.11 | -191.67 |
| Q04 2015 | -0.09 | -0.58 | -544.44 |
| Q03 2015 | 0.02 | 0.08 | 300.00 |
| Q02 2015 | 0.02 | 0.13 | 550.00 |
| Q01 2015 | 0.07 | 0.12 | 71.43 |
| Q04 2014 | - | 0.02 | - |
| Q03 2014 | 0.07 | 0.12 | 71.43 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 9/2019 QR | -0.03 | 0.00 | - |
| 12/2019 QR | -0.03 | 0.00 | - |
| 12/2020 FY | -0.21 | 0.00 | - |
| 12/2021 FY | -0.14 | 0.00 | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 301 |
| Shares Outstanding | 43.42K |
| Shares Float | 13.30M |
| Trades Count | 4 |
| Dollar Volume | 385 |
| Avg. Volume | 849 |
| Avg. Weekly Volume | 287 |
| Avg. Monthly Volume | 784 |
| Avg. Quarterly Volume | 1.48K |
Concord Medical Services Holdings Limited ADS (Each represents three) (NYSE: CCM) stock closed at 1.28 per share at the end of the most recent trading day (a -0.78% change compared to the prior day closing price) with a volume of 301.0000 shares and market capitalization of 55.57M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 738 people. Concord Medical Services Holdings Limited ADS (Each represents three) CEO is Jianyu Yang.
The one-year performance of Concord Medical Services Holdings Limited ADS (Each represents three) stock is -27.93%, while year-to-date (YTD) performance is -21.95%. CCM stock has a five-year performance of -63.74%. Its 52-week range is between 1.03 and 1.99, which gives CCM stock a 52-week price range ratio of 26.04%
Concord Medical Services Holdings Limited ADS (Each represents three) currently has a PE ratio of -0.80, a price-to-book (PB) ratio of 3.03, a price-to-sale (PS) ratio of 3.10, a price to cashflow ratio of 30.60, a PEG ratio of -, a ROA of -14.26%, a ROC of -34.46% and a ROE of 70.11%. The company’s profit margin is -89.01%, its EBITDA margin is -116.20%, and its revenue ttm is $21.53 Million , which makes it $0.50 revenue per share.
Of the last four earnings reports from Concord Medical Services Holdings Limited ADS (Each represents three), there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Concord Medical Services Holdings Limited ADS (Each represents three)’s next earnings report date is -.
The consensus rating of Wall Street analysts for Concord Medical Services Holdings Limited ADS (Each represents three) is — (0), with a target price of $1.2, which is -6.25% compared to the current price. The earnings rating for Concord Medical Services Holdings Limited ADS (Each represents three) stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Concord Medical Services Holdings Limited ADS (Each represents three) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Concord Medical Services Holdings Limited ADS (Each represents three) has a Sell technical analysis rating based on Technical Indicators (ADX : 22.48, ATR14 : 0.06, CCI20 : -43.87, Chaikin Money Flow : -0.04, MACD : -0.01, Money Flow Index : 50.46, ROC : 0.78, RSI : 47.85, STOCH (14,3) : 23.53, STOCH RSI : 0.17, UO : 57.75, Williams %R : -76.47), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Concord Medical Services Holdings Limited ADS (Each represents three) in the last 12-months were:
Concord Medical Services Holdings Limited ADS (Each represents three)
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
CEO: Jianyu Yang
Telephone: +86 1059036688
Address: 36 North Third Ring Road, Beijing 100013, , CN
Number of employees: 738
